Apimeds Pharmaceuticals US Inc banner
A

Apimeds Pharmaceuticals US Inc
AMEX:APUS

Watchlist Manager
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Watchlist
Price: 1.91 USD 17.18% Market Closed
Market Cap: $24m

Wall Street
Price Targets

APUS Price Targets Summary
Apimeds Pharmaceuticals US Inc

There are no price targets for APUS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Apimeds Pharmaceuticals US Inc Competitors:
Price Targets
PTEN
Patterson-UTI Energy Inc
-18% Downside
AFYA
Afya Ltd
15% Upside
PTCT
PTC Therapeutics Inc
34% Upside
VERK
Verkkokauppa.com Oyj
44% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
Apimeds Pharmaceuticals US Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Apimeds Pharmaceuticals US Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
Apimeds Pharmaceuticals US Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APUS's stock price target?
Not Available

APUS doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett